Ovarian Cancer News

News

Ovarian Cancer Action joins 21 other funders of cancer research wishing to maximise the value and benefits of cancer research for patients and the public.

News

The brand new NICE guideline ‘Ovarian cancer: identifying and managing familial and genetic risk’ has been published today. We break down what it means.

News

We outline what the programme is and answer some common questions.

News

At Ovarian Cancer Action, we want all women to survive ovarian cancer. We’re determined to make sure every woman gets the treatment they need when they need it. For World Cancer Day 2024, we went to the Houses of Parliament, alongside 20 cancer charities, to call on the Government and opposition parties to drastically reduce waiting times for cancer patients.

News

The National Institute for Health and Care Excellence have approved the combination of olaparib with bevacizumab for the maintenance treatment of high-grade epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.

News

We explore why women with a high inherited risk of cancer might opt to have their ovaries removed at the same time as having a caesarean section.

News

Our Grants and Impacts Manager, Faye, travelled to Boston to hear from the global voices in ovarian cancer research at a conference run by the American Association for Cancer Research. Faye talks through her time at the conference, the key speakers and meeting other charities with a united purpose.

News

The consultation period for the guidelines ‘Ovarian cancer: identifying and managing familial and genetic risk’ is open and we want you – our community – to have your voice heard.

News

The Isle of Man Anti-Cancer Association brought cancer awareness information to the local communities across the Island. We talk about how the charity started and why ovarian cancer awareness is so important to the people of the Isle of Man.

News

Professor Iain McNeish and his team at the Ovarian Cancer Action Research Centre have made two new discoveries that could lead to more women surviving ovarian cancer.

News

Our Head of Research and Policy, Marie-Claire Platt, travelled to Aberdeen for the British Gynaecological Cancer Society's annual meeting, to share the first results of our IMPROVE UK programme.

News

Today the results of the first pilots in the IMPROVE UK programme have been presented at the British Gynaecological Cancer Society annual conference in Aberdeen, Scotland.

News

Our researchers have discovered that relying on a single biopsy from a single location may not adequately represent the entire spectrum of a patient's tumour profile, potentially leading to suboptimal treatment decisions.

News

We all have BRCA genes. And men are just as likely as women to inherit a fault in those genes and pass them on to any children they have. So what do men and their families need to know when it comes to BRCA?

News

The National Institute for Health and Care Excellence has extended access to olaparib so that all patients with a BRCA gene mutation can now benefit from the drug

News

In a significant breakthrough for low grade serous ovarian cancer, a new drug combination has demonstrated the ability to shrink tumours in nearly half of the patients involved in a recent clinical trial.

News

Niraparib, (also known as Zejula), has been available in capsule form, but from this month it will be available across the UK in a tablet as well as a capsule.

News

The Call for Evidence is now opened to inform the Government's Major Conditions Strategy but we want you to know that your voices have and will be heard.

News

A new £2million project aims to discover whether a Risk of Ovarian Malignancy Algorithm (ROMA) blood test has a higher chance of detecting ovarian cancer earlier than the current CA125 blood test.

News

A new study has found that one in 100 people who have grandparents from Orkney, Scotland have the BRCA1 gene fault that increases the risk of developing breast and ovarian cancer.